Changes in the Receptorbinding Haemagglutinin Protein of Wild-type Morbilliviruses are not Required for Adaptation to Vero Cells

Virus Genes

Volumn 27, Issue 2, 2003, Pages 157-162

  Nielsen, Line ^a   Andersen, Mads Klindt ^a   Jensen, Tove Dannemann ^a   Blixenkrone Møller, Merete ^a   Bolt, Gert ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Canine distemper; Morbillivirus; Receptor; Wild type

Indexed keywords

CDW150 ANTIGEN; MEMBRANE COFACTOR PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS RECEPTOR;

ADAPTATION; ARTICLE; BRAIN INFECTION; CANINE DISTEMPER MORBILLIVIRUS; CELL ISOLATION; CONTROLLED STUDY; DOLPHIN; IN VITRO STUDY; MEASLES; MEASLES VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SUBACUTE SCLEROSING PANENCEPHALITIS; VERO CELL; VIRUS ISOLATION; VIRUS MUTATION; WILD TYPE;

ADAPTATION, BIOLOGICAL; ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; CERCOPITHECUS AETHIOPS; DISTEMPER VIRUS, CANINE; GLYCOPROTEINS; HEMAGGLUTININS, VIRAL; IMMUNOGLOBULINS; MEASLES VIRUS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MORBILLIVIRUS; MUTATION, MISSENSE; POINT MUTATION; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VERO CELLS;

CANINE DISTEMPER VIRUS; DOLPHIN MORBILLIVIRUS; MEASLES VIRUS; MORBILLIVIRUS; RNA VIRUSES;

EID: 0141958778     PISSN: 09208569     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025724526378     Document Type: Article

References (43)

1. Shibahara K., Hotta H., Katayama Y., and Homma M., J Gen Virol 75, 3511-3516, 1994.
2. Lecouturier V., Fayolle J., Caballero M., Carabana J., Celma M.L., Fernandez-Munoz R., Wild F., and Buckland R., J Virol 70, 4200-4204, 1996.
3. Bartz R., Brinckmann U., Dunster L.M., Rima B., ter Meulen V., and Schneider-Schaulies J., Virology 224, 334-337, 1996.
4. Buckland R. and Wild T.F., Virus Res 48, 1-9, 1997.
5. Rima B.K., Earle J.A.P., Baczko K., ter Meulen V., Liebert U.G., Carstens C., Carabana J., Caballero M., Celma M.L., and Fernandez-Munoz R., J Gen Virol 78, 97-106, 1997.
6. Hsu E.C., Sarangi F., Iorio C., Sidhu M.S., Udem S.A., Dillehay D.L., Xu W., Rota P.A., Bellini W.J., and Richardson C.D., J Virol 72, 2905-2916, 1998.
7. Takeda M., Kato A., Kobune F., Sakata H., Li Y., Shioda T., Sakai Y., Asakawa M., and Nagai Y., J Virol 72, 8690-8696, 1998.
8. Xie M.-F., Tanaka K., Ono N., Minagawa H., and Yanagi Y., Arch Virol 144, 1689-1699, 1999.
9. Nielsen L., Blixenkrone-Møller M., Thylstrup M., Hansen N.J.V., and Bolt G., Arch Virol 146, 197-208, 2001.
10. Schneider U., von Messling V., Devaux P., and Cattaneo R., J Virol 76, 7460-7467, 2002.
11. Blixenkrone-Møller M., Svansson V., Appel M., Krogsrud J., Have P., and Örvell C., Arch Virol 123, 279-294, 1992.
12. Blixenkrone-Møller M., Svansson V., Have P., Örvell C., Appel M., Pedersen I.R., and Dietz H.H., Vet Microbiol 37, 163-173, 1994.
13. Blixenkrone-Møller M., Bolt G., Gottschalck E., and Kenter M., J Gen Virol 75, 2829-2834, 1994.
14. Örvell C., Sheshberadaran H., and Norrby E., J Gen Virol 66, 443-456, 1985.
15. Shapshak P., Graves M.C., and Imagawa D.T., Virology 122, 158-170, 1985.
16. Bolt G., and Blixenkrone-Møller M., Vet Microbiol 41, 363-372, 1994.
17. Bolt G., Alexandersen S., and Blixenkrone-Møller M., J Gen Virol 76, 3051-3058, 1995.
18. Blixenkrone-Møller M., Bolt G., Dannemann Jensen T., Harder T., and Svansson V., Virus Res 40, 47-56, 1996.
19. Cattaneo R., Schmid A., Eschle D., Baczko K., ter Meulen V., and Billeter M.A., Cell 55, 255-265, 1988.
20. Wong T.C., Ayata M., Hirano A., Yoshikawa Y., Tsuruoka H., and Yamanouchi K., J Virol 63, 5464-5468, 1989.
21. Rota J.S., Wang Z.-D., Rota P.A., and Bellini W.J., Virus Res 31, 317-330, 1994.
22. Wild T.F., Malvoisin E., and Buckland R.J., Gen Virol 72, 439-442, 1991.
23. Cattaneo R. and Rose J.K., J Virol 67, 1493-1502, 1993.
24. Stern L.B.-L., Greenberg M., Gershoni J.M., and Rozenblatt S., J Virol 69, 1661-1668, 1995.
25. Lamb R.A., Virology 197, 1-11, 1993.
26. Manchester M., Eto D.S., Valsamakis A., Liton P.B., Fernandez-Munoz R., Rota P.A., Bellini W.J., Forthal D.N., and Oldstone M.B.A., J Virol 74, 3967-3974, 2000.
27. Waku Kouumou D., and Wild T.F., J Virol 76, 1505-1509, 2002.
28. Naniche D., Varior-Krishnan G., Cervoni F., Wild T.F., Rossi B., Rabourdin-Combe C., and Gerlier D., J Virol 67, 6025-6032, 1993.
29. Dörig R.E., Marcil A., Chopra A., and Richardson C.D., Cell 75, 295-305, 1993.
30. Tatsuo H., Nobuyuki O., Tanaka K., and Yanagi Y., Nature 406, 893-897, 2000.
31. Erlenhoefer C., Wurzer W.J., Löffler S., Schneider-Schaulies S., ter meulen V., and Schneider-Schaulies J., J Virol 75, 4499-4505, 2001.
32. Hsu E.C., Iorio C., Sarangi F., Khine A.A., and Richardson C.D., Virology 279, 9-21, 2001.
33. Maisner A., Schneider-Schaulies J., Liszewski M.K., Atkinson J.P., and Herrler G., J Virol 68, 6299-6304, 1994.
34. Murakami Y., Seya T., Kurita M., and Nagasawa S., Biol Pharm Bull 19, 1541-1545, 1996.
35. Löffler S., Lottspeich F., Lanza F., Azorsa D.O., ter meulen V., and Schneider-Schaulies J., J Virol 71, 42-49, 1997.
36. Galbraith S.E., Tiwari A., Baron M.D., Lund B.T., Barrett T., and Cosby S.L., J Virol 72, 10292-10297, 1998.
37. Tatsuo H., Nobuyuki O., and Yanagi Y., J Virol 75, 5842-5850, 2001.
38. Tangye S.G., Phillips J.H., and Lanier L.L., Sem Immunol 12, 149-157, 2000.
39. Takeuchi K., Takeda M., Miyajima N., Kobune F., Tanabayashi K., and Tashiro M., J Virol 76, 4891-4900, 2002.
40. McQuaid S. and Cosby S.L., Lab Invest 82, 403-409, 2002.
41. Hashimoto K., Ono N., Tatsuo H., Minagawa H., Takeda M., Takeuchi K., and Yanagi Y., J Virol 76, 6743-6749, 2002.
42. Andres O., Obojes K., Kim K.S., ter Meulen V., and Schneider-Schaulies J., J Gen Virol 84, 1189-1197, 2003.
43. Bolt G., Danneman Jensen T., Gottschalck E., Arctander P., Appel M.J.G., Buckland R., and Blixenkrone-Moøller M., J Gen Virol 78, 367-372, 1997.